3 lessons from our immune systems on how to tackle COVID-19
Here are three ways to decode the signals from our immune systems to help us understand and fight COVID-19 - and to prepare us for any future pandemics.
Co-founded MeMed in 2009 and has served as its Chief Executive Officer, leading it from an idea to a rapidly growing company. Has 15 years of combined business and academic experience leading the development of cutting-edge multidisciplinary technologies that synergize molecular biology and informatics. Co-founded several highly funded international consortia (e.g., Tailored-Treatment and AutoPilot-Dx), the mission of which is to develop, clinically validate and commercialize novel technologies for diagnosing patients with infectious diseases and inflammatory disorders. BSc (Hons) in Computer Engineering, BA (Hons) in Biology, and MSc (Hons) in Computer Science, Technion, Israel Institute of Technology; PhD in Systems Biology, Weizmann Institute of Science. Co-Author of over 20 peer-reviewed publications and over 80 patents and patent applications. Recipient of multiple awards, including the GE and Science Prize for Promising Life Scientists.